List | Section | Observation |
---|---|---|
Chile | Essential and Prioritized Medications | No observations |
Colombia | 7.1 Coagulants and Hemostatics | No observations |
WHO Model List of Essential Medicines (2021) | 11.2.2 Blood coagulation factors |
Others observations: Therapeutic alternatives to be reviewed (2023) |
WHO Model List of Essential Medicines (2021) | 11.2.2 Blood coagulation factors |
Others observations: Therapeutic alternatives to be reviewed (2023) |
List | Section | Observation |
---|---|---|
Chile | Essential and Prioritized Medications | No observations |
Colombia | 7.1 Coagulants and Hemostatics | No observations |
WHO Model List of Essential Medicines (2021) | 11.2.2 Blood coagulation factors |
Others observations: Therapeutic alternatives to be reviewed (2023) |
WHO Model List of Essential Medicines (2021) | 11.2.2 Blood coagulation factors |
Others observations: Therapeutic alternatives to be reviewed (2023) |
List | Section | Observation |
---|---|---|
Cuba | 11.2 Fracciones plasmáticas para usos específicos | No observations |
List | Section | Observation |
---|---|---|
Venezuela (incomplete) | List of Generic Medications - Venezuela | No observations |